4-Fluorophenoxyacetic acid hydrazide

CAS : 1737-62-8

Ref. 3D-FF38787

Informations sur le produit

• Nom: 4-Fluorophenoxyacetic acid hydrazide
• Synonymes: Akos B015229, Akos Au36-M58, 2-(4-Fluorophenoxy)Acetic Acid Hydrazide, 2-(4-Fluorophenoxy)Acetohydrazide

Description

4-Fluorophenoxyacetic acid hydrazide (4FPAAH) is a palladium complex with anti-cancer activity. It induces apoptosis, or programmed cell death, in myelogenous leukemia cells and breast cancer cells. 4FPAAH has been shown to bind to the ATP binding site of the catalytic domain of topoisomerase II on DNA and inhibit its activity. The molecular modeling studies show that 4FPAAH binds in the same way as cisplatin, which is a platinum-based drug commonly used for cancer treatment. The structural analysis shows that 4FPAAH binds to the nitrogen atoms of the protein and eliminates the possibility of any hydrogen bonding interactions. This mechanism may be due to an electrostatic interaction between the positively charged nitrogen atom in 4FPAAH and negative charge on topoisomerase II's active site.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 184.17 g/mol
• Formule: C₈H₉FN₂O₂
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder
• InChI: InChI=1S/C8H9FN2O2/c9-6-1-3-7(4-2-6)13-5-8(12)11-10/h1-4H,5,10H2,(H,11,12)
• Code InChI: InChIKey=SEIHQPCBPNHCBN-UHFFFAOYSA-N
• SMILES: NNC(=O)COc1ccc(F)cc1